Solving the R-Conotoxin Folding Problem
A R T I C L E S
74 µm mesh polypropylene bags with the dimension of 5 × 5 cm.
Side-chain deprotection was achieved by 10 mL HF treatment at 0
°C for 2 h with p-cresol as scavengers [9:1 (v/v) HF:scavenger].
HF was evaporated and the solid support was directly transferred
into TFA to maintain the swelling properties. The resins were
washed with DCM, DMF, and H2O before being placed into a 0.1
M NH4HCO3 solution (100 mg /10 mL) at pH 8.4. The final
cleavage was performed either by reductive acidolysis with NH4I/
TFA/DMS for 1 h at 0 °C and 1 h at room temperature.26 TFA
was then evaporated by nitrogen purging, the peptides were
precipitated and the scavengers removed with cold ethyl acetate.
The peptides were redissolved in H2O, 0.1% TFA and lyophilized.
After MS and analytical RP-HPLC analysis, the peptides were
purified by C18-RP-HPLC.
4.3. Contraction Bioassay Rat Diaphragm and Electrophys-
iologysXenopus Oocytes. RNA preparation, oocyte preparation,
and expression of nAChRs in Xenopus oocytes were performed as
previously described.40 The methods and experimental protocols
for the rat diaphragm contraction bioassay and the electrophysi-
ological assays using Xenopus oocytes can be found in the Sup-
porting Information.
4.4. Circular Dichroism (CD) Spectroscopy. CD spectroscopy
was performed on a Jasco J-810 spectropolarimeter. Spectra were
recorded at room temperature under nitrogen atmosphere. Peptides
were dissolved in 20 mM phosphate buffer, containing 30%
trifluoroethanol at pH 7. The peptide concentration was determined
by quantitative RP-HPLC. The peptides were transferred into a
0.01 cm path length demountable cell and data were recorded over
5 scans, from 260 to 185 at 10 nm/min, with a resolution of 1 nm
and a response time of 0.25 s. CD data in ellipticity was converted
to mean residue ellipticity ([θ]R) using the equation: [θ]R ) θ/(10
× C × Np × l) where θ is the ellipticity in millidegrees, C is the
peptide molar concentration (M), l is the cell path length (cm), and
Np is the number of peptide residues.
of activity (10-fold) and hydrophobicity (see Table 1 and Figure
5 c and d). Such a change in hydrophobicity in combination
with small changes in bond length and torsion angle are likely
to strengthen hydrophobic interactions between the diselenide
bond and the two tyrosine residues or in changing in the binding
orientation, which subsequently increases the hydrophobic
contacts with conserved aromatic residues in the binding site.
Another anticipated advantage of selenoconotoxins is their
higher stability in reducing environments due to the lower redox
potential of the diselenide.18,19,21 RP-HPLC and LC-MS
studies on AuIB and the R-selenoconotoxin Sec[1,3]-AuIB and
Sec[2,4]-AuIB performed in solutions containing equimolar
glutathione or rat plasma at physiological pH demonstrated that
a single diselenide bond was able to largely suppress scrambling
(see Figure 4). However, the selenium analogs showed a similar
half-life to the native peptides in plasma, confirming that the
main degradation occurs mostly via enzymatic digestion. In
order to improve the plasma stability of this class of peptides
even more, N- to C-terminal cyclization is currently the method
of choice and significant progress has been achieved in this field
recently.38,39
In summary, we have developed a novel, highly scalable
method amenable to high throughput R-conotoxin synthesis that
employs resin-supported selenium-chemistry to solve a long-
standing folding problem of an important class of subtype-
selective nAChR antagonists. Stability studies and electrophys-
iological analysis revealed that the selenium analogs of
R-conotoxins are more potent and stable than their native
counterparts. Comprehensive structural analysis showed that the
slightly larger atomic radius of selenium has no significant
impact on the overall structure. Surface analysis and investiga-
tion of the binding pocket of AChBP revealed that the increase
in hydrophobicity of the diselenide bond is likely to be the
reason for observed increase in potency of this toxin class. This
methodology is highly complementary to native chemical
ligation and orthogonal thiol-protecting group strategies and is
anticipated to provide access to more complex disulfide rich
peptides or proteins with similar folding challenges.19,35
4.5. NMR Spectroscopy. NMR spectra were recorded at 290
K on a Bruker Avance 600 MHz spectrometer and processed using
Topspin (Bruker Corp. Billerica, MA, USA) software. The con-
1
centration for the H NMR measurements was ∼1 mM peptide in
90% H2O/ 10% D2O (v/v) at pH 3. 2D NMR spectra were recorded
in phase-sensitive mode using time-proportional phase incremen-
tation for quadrature detection in the t1 dimension.41 The 2D
experiments consisted of a TOCSY using a MLEV-17 spin lock
sequence42 with a mixing time of 80 ms, and NOESY with a mixing
time of 250 ms. Solvent suppression was achieved using a modified
WATERGATE sequence. Spectra were acquired over 6024 Hz with
4096 complex data points in F2 and 512 increments in the F1
dimension. The t1 dimension was zero-filled to 1024 real data points,
and 90° phase-shifted sine bell window functions were applied prior
to Fourier transformation. Chemical shifts were referenced to
internal 2, 2-dimethyl-2-silapentane- 5-sulfonate.
4. Methods
4.1. Peptide Synthesis. All peptides were assembled by manual
Boc-SPPS using HBTU-mediated in situ neutralization protocol
with DMF as solvent.23 Deprotection of the 2,4-dinitrophenyl (Dnp)
group of histidine was carried out prior to HF treatment with 20%
2-mercaptoethanol/ 10% DIEA/ DMF. HF deprotection or cleavage
was performed by treatment of the dried peptide resin (300 mg)
with 10 mL HF/p-cresol/p-thio-cresol (18:1:1, v/v/v) for 2 h at 0
°C. Following evaporation of the HF, the peptides were precipitated
and washed with cold ether, filtered, and either redissolved in 30
mL of 50% ACN/1% TFA and lyophilized, or redissolved directly
in 0.1 M NH4HCO3 (pH 8.4, c ) 0.1 µM) for direct oxidation.
Oxidation was monitored by RP-HPLC, LC-MS and MS, and
the peptides were isolated using preparative C18 RP-HPLC.
4.2. On-Resin Folding using a Safety-Catch Acid Labile
(SCAL) Linker. Peptide assembly was achieved by manual Boc-
SPPS23 using the Fmoc-SCAL linker and a three glycine spacer
between the linker and the aminomethyl ChemMatrix resin.
Deprotection of the Fmoc group of the SCAL linker was performed
with 2× 1 min treatment of 50% piperidine/DMF. 100-500 mg
of the individual peptides on-resin were transferred into labeled
4.6. Glutathione Stability Assay. Peptide samples (0.3 mM)
were dissolved in a solution containing 0.3 mM reduced glutathione
(Sigma Aldrich) in 100 mM phosphate buffer, pH 7.2 and incubated
at 37 °C. Aliquots (30 mL) were taken at different time points,
quenched with extraction buffer (70 mL) consisting of 50% aqueous
acetonitrile, 100 mM NaCl and 1% TFA, and analyzed by
RP-HPLC and LC-MS.21
4.7. Rat Plasma Stability Assay. Rat plasma (Sigma Aldrich)
was incubated at 37 °C for 30 min and 300 mL of plasma was added
to 50 mL of 0.3 mM peptide sample in 100 mM phosphate buffer,
pH 7.2. The samples were incubated at 37 °C and aliquots (30 mL)
were taken at different time points, quenched with extraction buffer
(40) Clark, R. J.; Fischer, H.; Nevin, S. T.; Adams, D. J.; Craik, D. J.
J. Biol. Chem. 2006, 281, 23254–23263.
(41) Marion, D.; Wu¨thrich, K. Biochem. Biophys. Res. Commun. 1983, 113,
967–974.
(38) Clark, R. J.; Fischer, H.; Dempster, L.; Daly, N. L.; Rosengren, K. J.;
Nevin, S. T.; Meunier, F. A.; Adams, D. J.; Craik, D. J. Proc. Natl.
Acad. Sci. U.S.A. 2005, 102, 13767–13772.
(42) Bax, A.; Davis, D. G. J. Magn. Reson. 1985, 65, 355–360.
(43) Azam, L.; Dowell, C.; Watkins, M.; Stitzel, J. A.; Olivera, B. M.;
McIntosh, J. M. J. Biol. Chem. 2005, 280, 80–87.
(39) Craik, D. J.; Adams, D. J. ACS Chem. Biol. 2007, 2, 457–468.
9
J. AM. CHEM. SOC. VOL. 132, NO. 10, 2010 3521